Preliminary evaluation of the clinical utility of miRNA as neurobiological markers of TBI diagnosis and rTMS treatment responsiveness
Saved in:
| Main Author: | Theresa Bender Pape |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
Elsevier
2021
|
| Subjects: | |
| Online Access: | https://doaj.org/article/1af478213ae049bc97cf111b2315066f |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Customizing rTMS treatment targeting for co-occurring alcohol use disorder and mild traumatic brain injury using multi-modal neuroimaging data as neurobiological markers
by: Amy Herrold, et al.
Published: (2021) -
High Frequency rTMS Dosing for Smoking Cessation: Preliminary Findings
by: Christine Sheffer, et al.
Published: (2021) -
rTMS Dosing for Smoking Cessation: Pre-COVID Preliminary Results
by: Chrisitine Sheffer, et al.
Published: (2021) -
Combined rTMS/fMRI over the Motor and Prefrontal Brain Areas for Testing Therapeutic rTMS Protocols
by: Kai-Yen Chang, et al.
Published: (2021) -
Superior antidepressant effect occurring 1 month after rTMS: add-on rTMS for subjects with medication-resistant depression
by: Chen SJ, et al.
Published: (2013)